Immucell Corp. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
117.40
167.20
1,213.20
508.40
168.10
2,321.70
Depreciation, Depletion & Amortization
417.20
446.00
525.90
802.40
904.40
1,520.70
Other Funds
0.40
-
25.70
-
-
337.40
Funds from Operations
688.30
227.70
2,585.10
1,652.00
642.90
676.10
Changes in Working Capital
410.40
74.70
315.10
1,975.90
532.90
302.70
Net Operating Cash Flow
1,098.70
302.40
2,900.20
323.90
1,175.80
373.40
Capital Expenditures
597.70
1,535.60
2,719.20
3,586.30
17,759.90
Sale of Fixed Assets & Businesses
-
-
66.20
30.90
45.00
Purchase/Sale of Investments
745.00
-
1,966.00
499.00
5,450.00
Net Investing Cash Flow
1,342.70
1,535.60
4,619.00
4,422.60
12,273.50
Issuance/Reduction of Debt, Net
181.40
190.30
2,296.10
182.60
5,928.30
Net Financing Cash Flow
159.30
187.20
2,442.00
8,323.50
9,746.20
Net Change in Cash
403.30
1,420.40
723.30
3,577.00
1,351.50
Free Cash Flow
501.00
1,233.20
181.10
3,910.30
16,584.10
Deferred Taxes & Investment Tax Credit
87.20
88.60
821.50
236.30
284.80
462.30
Net Assets from Acquisitions
-
-
-
368.20
8.70
Change in Capital Stock
21.80
3.10
120.20
8,506.10
3,817.90
About Immucell
View Profile
